| Literature DB >> 33125402 |
Keith Hellen Dias da Silva Lira1, Thaís Souza Passos2, Heryka Myrna Maia Ramalho3, Karla Danielly da Silva Ribeiro Rodrigues1,2, Érica de Andrade Vieira4, Angela Maria Tribuzy de Magalhães Cordeiro4, Bruna Leal Lima Maciel1,2, Karla Suzanne Florentino da Silva Chaves Damasceno1,2, Francisco Canindé de Sousa Júnior1,5, Cristiane Fernandes de Assis1,5.
Abstract
TheEntities:
Mesh:
Substances:
Year: 2020 PMID: 33125402 PMCID: PMC7598505 DOI: 10.1371/journal.pone.0240889
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Formulations produced to obtain quinoa oil loaded particles.
| Formulations | Oil phase (quinoa oil) (g) | Aqueous phase 1 (90 mL) | Aqueous phase 2 (100 mL) | |||
|---|---|---|---|---|---|---|
| Tween 20 (% w/v) | Whey protein isolate (% w/v) | Tween 20 (% w/v) | Porcine gelatin (% w/v) | Whey protein isolate (% w/v) | ||
| 4 | 1.5 | - | 1.5 | 4.0 | - | |
| 4 | 1.5 | - | 1.5 | 3.0 | 1.0 | |
| 4 | 1.5 | 1.0 | 1.5 | 3.0 | - | |
OG: Quinoa oil and porcine gelatin in aqueous phase 2; OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2; OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2.
Fatty acids profile of quinoa oil (Chenopodium quinoa Willd.) determined by gas chromatography of fatty acid methyl esters.
| Fatty acids | % |
|---|---|
| C10:0 (capric acid) | ND |
| C12:0 (Lauric acid) | ND |
| C14:0 (Myristic acid) | 0.68 |
| C16:0 (Palmitic acid) | 24.20 |
| C16:1 (Palmitoleic acid) | 0.53 |
| C17:0 (Heptadecanoic acid) | ND |
| C18:0 (Stearic acid) | 2.15 |
| C18:1n-9c (Oleic acid) | 15.52 |
| C18:1n-9t (Elaidic acid) | 0.81 |
| C18:2n-6c (linoleic acid) | 55.39 |
| C18:2n-6t (linolelaidic acid) | 0.72 |
| C18:3n-3 (α-linolenic acid) | ND |
| C20:0 (Arachidic acid) | ND |
| C20:1n-9 (Gandoic acid) | ND |
| C22:0 (Behenic acid) | ND |
| Saturated FattyAcids | 27.03 |
| Monounsaturated Fatty Acids | 16.86 |
| Polyunsaturated Fatty Acids | 56.11 |
*Not detected.
Fig 1Powder encapsulates containing quinoa oil (Chenopodium quinoa Willd.) obtained by O/W emulsification technique.
(A) OG: Quinoa oil and porcine gelatin in aqueous phase 2; (B) OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2; (C) OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2.
Fig 2Micrographs of powdered particles, dispersed in acetone, obtained by O/W emulsification technique.
(A) OG: Quinoa oil and porcine gelatin in aqueous phase 2; (B) OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2; (C) OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2.
Fig 3Particle size distribution by laser diffraction of encapsulated powder particles obtained by O/W emulsification technique.
(A) OG: Quinoa oil and porcine gelatin in aqueous phase 2; (B) OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2; (C) OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2.
Fig 4FTIR spectra of powder particles obtained by O/W emulsification technique (A) OG: Quinoa oil and porcine gelatin in aqueous phase 2 –a. OG, b. Tween 20, c. quinoa oil, d. porcine gelatin; (B) OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2 –a. OWG1, b. Tween 20, c. quinoa oil, d. porcine gelatin, e. whey protein isolated; (C) OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2—a. OWG2, b. Tween 20, c. quinoa oil, d. porcine gelatin, e. whey protein isolated.
Fig 5X-ray diffractograms of encapsulating agents and powder particles obtained by O/W emulsification technique.
(A) porcine gelatin; (B) whey protein isolated; (C) OG: Quinoa oil and porcine gelatin in aqueous phase 2; (D) OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2; (E) OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2.
Fig 6Dispersibility percentages for crude Quinoa Oil (QO) and powder particles obtained by O/W emulsification technique.
(A) OG: Quinoa oil and porcine gelatin in aqueous phase 2; (B) OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2; (C) OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2. The values were compared to each other by means of variance analysis with Tukey post-hoc (p < 0.05). *Mean and standard deviation (SD), n = 3. *Equal letters mean that there was no significant difference, according to Tukey post-hoc (p>0.05).
Antioxidant activity (IC50) for crude Quinoa Oil (QO) and powder particles obtained by O/W emulsification technique.
| Formulation | IC50 (mg/mL) |
|---|---|
| QO | 13.36 (0.28)a |
| OG | 8.92 (0.63)b |
| OWG 1 | 5.30 (0.19)c |
| OWG 2 | 5.54 (0.27)c |
OG: Quinoa oil and porcine gelatin in aqueous phase 2; OWG1: Quinoa oil, whey protein isolate and porcine gelatin in aqueous phase 2; OWG2: Quinoa oil, whey protein isolate in aqueous phase 1, and porcine gelatin in aqueous phase 2. The values were compared to each other by means of variance analysis with Tukey post-hoc (p < 0,05).
*Mean and standard deviation (SD), n = 3. The different lowercase (a, b and c) letters indicate a statistical difference (p<0.05). Values with the same lowercase letter are not significantly different, according to Student’s test.